AmeriCann, Inc.

Equities

ACAN

US0305881072

Healthcare Facilities & Services

Market Closed - OTC Markets 02:01:53 2024-04-26 pm EDT 5-day change 1st Jan Change
0.061 USD 0.00% Intraday chart for AmeriCann, Inc. -6.44% -28.24%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
AmeriCann, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
AmeriCann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Americann, Inc. Announces Loan Modification Agreement CI
AmeriCann, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
AmeriCann, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI
Earnings Flash (ACAN) AMERICANN Posts Q4 Revenue $734.8M MT
Earnings Flash (ACAN) AMERICANN Posts Q4 Revenue $734,764 MT
AmeriCann, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022 CI
AmeriCann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022 CI
AmeriCann, Inc. Auditor Raises 'Going Concern' Doubt CI
Americann, Inc. Reports Sales Results for the Period Ended September 2022 CI
AmeriCann, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022 CI
AmeriCann, Inc. Reports Sales Results for the Month and Quarter Ended June 2022 CI
AmeriCann, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022 CI
AmeriCann, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021 CI
AmeriCann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2021 CI
AmeriCann, Inc. Auditor Raises 'Going Concern' Doubt CI
Americann, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021 CI
Americann, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021 CI
Americann, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2020 CI
Americann Launches Respected Cannabis Products Out of AmeriCann's Development, the Massachusetts Cannabis Center CI
Americann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2020 CI
AmeriCann, Inc. Auditor Raises 'Going Concern' Doubt CI
AmeriCann Received Two Licenses from the Massachusetts Cannabis Control Commission CI
AmeriCann, Inc. Benefits from Increased Production/Sales at its Massachusetts Cannabis Center CI
Chart AmeriCann, Inc.
More charts
AmeriCann, Inc. is a cannabis company that develops cultivation, processing and product manufacturing facilities. It has provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals and concentrates. It designs GMP-certified cannabis extraction and product manufacturing infrastructure. Its flagship project is the Massachusetts Cannabis Center (MCC), which is being developed on a 52-acre parcel. MCC project is permitted for over 800,000 square feet of cannabis cultivation and processing infrastructure which is being developed in phases to support both the existing medical cannabis and the emerging adult-use cannabis marketplace. The Company, through a 100% owned subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated market.
More about the company
  1. Stock Market
  2. Equities
  3. ACAN Stock
  4. News AmeriCann, Inc.
  5. Earnings Flash (ACAN) AMERICANN Posts Q4 Revenue $734.8M